• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    Neurocrine Biosciences, Inc. (NBIX)

    -NasdaqGS
    42.72 Down 0.36(0.84%) Feb 24, 4:00PM EST
    |After Hours : 42.41 Down 0.31 (0.72%) Feb 24, 4:11PM EST
    Prev Close:43.08
    Open:42.78
    Bid:37.50 x 100
    Ask:56.02 x 100
    1y Target Est:67.67
    Beta:1.72828
    Earnings Date:May 3 - May 8 (Est.)
    Day's Range:41.89 - 43.14
    52wk Range:32.18 - 55.15
    Volume:651,609
    Avg Vol (3m):1,106,840
    Market Cap:3.71B
    P/E (ttm):N/A
    EPS (ttm):-1.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXDown 0.84%3.71B
    LLYUp 0.39%86.94B
    PFEUp 0.59%207.90B
    ABTUp 0.62%78.85B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):250.19
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-17) :-2.34
    Quarterly EPS Est (Mar-17) :-0.74
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.51

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback